The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
about
Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation resultsStable self-serving personality traits in recreational and dependent cocaine usersRisky Decisions in a Lottery Task Are Associated with an Increase of Cocaine Use.Interventions to Reduce Drug Abuse in Pars Special Economic Energy Zone.Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study.Comparing drug detection in oral fluid and blood: data from a national sample of nighttime drivers.Use of alcohol and drugs among health professionals in Norway: a study using data from questionnaires and samples of oral fluid.Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challengeUse of alcohol and drugs by Norwegian employees: a pilot study using questionnaires and analysis of oral fluid.Measurement of rivaroxaban and apixaban in serum samples of patients.Surface-assisted laser desorption ionization mass spectrometry techniques for application in forensics.Oral fluid testing for drugs of abuse.Monitoring pregnant women's illicit opiate and cocaine use with sweat testing.MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.Current knowledge on cannabinoids in oral fluid.Quantification of 11-nor-9-carboxy-δ9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry.Concentrations of Morphine and Codeine in Paired Oral Fluid and Urine Specimens Following Ingestion of a Poppy Seed Roll and Raw Poppy SeedsRapid Analysis of Cocaine in Saliva by Surface-Enhanced Raman Spectroscopy.Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administrationEmployment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial.Urine toxicology testing in chronic pain management.Advanced urine toxicology testing.Optofluidic opportunities in global health, food, water and energy.Hair as an alternative matrix in bioanalysis.Trends in drug testing in oral fluid and hair as alternative matrices.The impact of military service and traumatic brain injury on the substance use norms of Army Reserve and National Guard Soldiers and their spouses.Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds.Bioanalysis of urine samples after manipulation by oxidizing chemicals: technical considerations.Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.Fentanyl-Norfentanyl Concentrations During Transdermal Patch Application: LC-MS-MS Urine Analysis.Racial/ethnic differences in report of drug testing practices at the workplace level in the U.S.Comparison of analytical approaches for liquid chromatography/mass spectrometry determination of the alcohol biomarker ethyl glucuronide in urine.Time-course measurements of caffeine and its metabolites extracted from fingertips after coffee intake: a preliminary study for the detection of drugs from fingerprints.Catching Fakes: New Markers of Urine Sample Validity and Invalidity.Changes in cocaine consumption are associated with fluctuations in self-reported impulsivity and gambling decision-making.A high-throughput method based on microwave-assisted extraction and liquid chromatography-tandem mass spectrometry for simultaneous analysis of amphetamines, ketamine, opiates, and their metabolites in hair.Alcohol and drug testing of health professionals following preventable adverse events: a bad idea.Synthesis of a novel polymeric magnetic solid phase extraction adsorbent for selective extraction of amphetamine from urine samples coupled with high performance liquid chromatography.Fast GC-MS method for the simultaneous screening of THC-COOH, cocaine, opiates and analogues including buprenorphine and fentanyl, and their metabolites in urine.In situ assembly of active surface-enhanced Raman scattering substrates via electric field-guided growth of dendritic nanoparticle structures.
P2860
Q28249957-F681F0A6-3AEE-4F2A-A4B1-6CD265C45F93Q30361343-A4869889-AE40-4EC7-82B4-704F1D49E7C5Q30382802-4A1ABF75-AC06-46C0-9CD1-D2025257AF29Q30386425-26274939-4920-4312-B152-93996CF86E32Q30405899-87987230-BAC7-4699-8A5E-4A72482C5C21Q30717175-F035A6FD-322F-41B0-8814-D378C79F14BAQ30773778-C3B35679-ECFD-4CFA-9A9E-E7C2FD059DA7Q33915426-24FDE237-F106-488B-839C-6EF546B7E7F7Q34008868-10E87074-7E91-4EC1-9FED-61E98E0591BEQ34086522-2EEC3F33-1D70-4462-BB39-FD212ED6B3EFQ35185035-D1CC1A50-DEC5-43A9-86F6-9FDB239C423AQ35190524-10EA643F-B039-4061-9264-A261244F689AQ35196693-59B074B3-BA7C-4900-9852-2D96FE038239Q35228063-37B750DA-330D-40EE-8D16-4444C76A7346Q35940339-566F9D68-173B-4F0C-B060-885CCC7E24EDQ35963506-AD843683-9711-4DDE-A54A-6C7AF9F543FAQ36062684-62AD94B3-103A-4B71-9464-72E13E599458Q36497609-63B69A53-283E-4A3D-BEF0-21D4B6688509Q36800106-B22CBBDF-E7F3-4CBE-9687-C1133B75AF45Q37312774-76510D1D-2D6D-482F-9670-4CCD7D971D6BQ37566070-6723828F-2F49-4AD8-95A8-E9944D311633Q37798213-7D275E90-6F40-487A-9980-36361D9D9149Q38024024-190FE4E6-D27C-45BA-8DB6-BAC86B007A7DQ38099401-ABBDAB42-0F7E-4E3C-9EAB-9937F3B0F182Q38266511-BE6B2A51-0D66-4329-82E3-35BDA3AB1408Q38733508-E4317BE9-92A6-43D0-9FC1-9E8F6B6EA3BBQ38785676-118B122F-7CE5-4E85-9D39-5CC5911CB2E9Q39156457-68AEA57E-1A52-4612-9E3B-0458E9B09212Q39172040-BF1803F3-DDC8-4349-8248-17033A03F973Q39609522-E42ABC7B-ABB3-433B-89F7-9DDD8ABB57E5Q40142769-1AA872B2-52B0-4051-B58B-165221E0BB33Q43055119-CCB0BDDC-CF72-4F99-8B1C-3CBAE383F375Q43946083-96847077-631A-45C5-9A41-8A9E3F9F23FCQ47382034-61E646DC-DADF-49DD-BCFD-A44393EB8F29Q47688396-88BACB41-D63C-45D0-9DE8-185759380C98Q47902350-D3C7FB41-D9BD-4F72-BB36-60ABD21D4FD9Q48060810-6EBD2D96-F0A3-4350-ACA7-726FDF4C6268Q48277969-27569FB7-A16B-4AAC-8BD5-6DA504242A19Q48305385-B37395D3-9B5F-4EFD-A148-13EE18E3F843Q50616077-324033D5-B673-4120-91BC-D32761FA4FF5
P2860
The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The U.S. Mandatory Guidelines ...... tus and future considerations.
@ast
The U.S. Mandatory Guidelines ...... tus and future considerations.
@en
type
label
The U.S. Mandatory Guidelines ...... tus and future considerations.
@ast
The U.S. Mandatory Guidelines ...... tus and future considerations.
@en
prefLabel
The U.S. Mandatory Guidelines ...... tus and future considerations.
@ast
The U.S. Mandatory Guidelines ...... tus and future considerations.
@en
P1476
The U.S. Mandatory Guidelines ...... tus and future considerations.
@en
P2093
Donna M Bush
P304
P356
10.1016/J.FORSCIINT.2007.03.008
P577
2007-04-16T00:00:00Z